Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Univercells Launches CDMO to Support Cell and Gene Therapy Developers

March 19, 2020

Belgian-based bioprocessing provider, Univercells, has launched a CDMO, Exothera, that will support developers of cell and gene therapies through process development and production of viral vectors.

Challenges in Clinical Manufacturing for Topical Drugs

March 02, 2020

Understanding of scale-up parameters and use of process analytical technology are important to meet demand for larger batch sizes.

Stability Testing: The Crucial Development Step

March 02, 2020

As compounds become more complex in nature and biological ingredients are more widely used, stability testing approaches must follow suit and provide flexibility for developers.

Keeping Toxicity to a Minimum

March 02, 2020

Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.

The Benefits of Outsourcing Stability Testing

March 02, 2020

Outsourcing stability testing to full-service providers can offer comprehensive benefits to bio/pharma companies.

By Popular Demand: The Growth of Biopharma Outsourcing

March 02, 2020

The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.

Fast vs. Formulated?

March 02, 2020

Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?

Eurofins DiscoverX Grants Bioassay Certification to VelaLabs

February 28, 2020

Pharmaceutical Technology's In the Lab eNewsletter

Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.

ERS Genomics, Aelian Biotechnology in CRISPR/Cas9 License Agreement

February 28, 2020

Pharmaceutical Technology's In the Lab eNewsletter

Under the agreement, ERS Genomics will license its gene-editing technology to Aelian Biotechnoloy to support its commercial functional genomic screening platform.

Vectura Appoints Sharon Johnson Executive VP

February 12, 2020

Inhalation drug delivery company Vectura announces new organizational structure to drive innovation, customer focus, and growth.